Inovio Pharmaceuticals Inc. (INO): Investing has never been easier – Invest Chronicle
Home  »  Stock   »  Inovio Pharmaceuticals Inc. (INO): Investing has n...

Inovio Pharmaceuticals Inc. (INO): Investing has never been easier

Let’s start up with the current stock price of Inovio Pharmaceuticals Inc. (INO), which is $1.93 to be very precise. The Stock rose vividly during the last session to $2.05 after opening rate of $2.01 while the lowest price it went was recorded $1.77 before closing at $1.88.Recently in News on May 23, 2022, INOVIO to Present at Jefferies 2022 Healthcare Conference. INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious diseases and treat people with cancer and HPV-associated diseases, today announced that Jacqueline Shea, Ph.D., President and CEO, and Jeffrey Skolnik, M.D., SVP of Clinical Development for Oncology and HPV Therapeutics, are scheduled to participate in a fireside chat and 1×1 investor meetings at the Jefferies 2022 Healthcare Conference on Wednesday, June 8th, 2022 at 1:00 PM EDT. You can read further details here

Inovio Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.2700 on 01/04/22, with the lowest value was $1.6000 for the same time period, recorded on 05/11/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Inovio Pharmaceuticals Inc. (INO) full year performance was -73.37%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Inovio Pharmaceuticals Inc. shares are logging -81.32% during the 52-week period from high price, and 20.62% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.60 and $10.33.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 7350398 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Inovio Pharmaceuticals Inc. (INO) recorded performance in the market was -62.32%, having the revenues showcasing -40.88% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 451.20M, as it employees total of 317 workers.

Analysts verdict on Inovio Pharmaceuticals Inc. (INO)

According to the data provided on, the moving average of the company in the 100-day period was set at 3.4328, with a change in the price was noted -3.25. In a similar fashion, Inovio Pharmaceuticals Inc. posted a movement of -62.54% for the period of last 100 days, recording 5,202,306 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for INO is recording 0.05 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.05.

Inovio Pharmaceuticals Inc. (INO): Technical Analysis

Raw Stochastic average of Inovio Pharmaceuticals Inc. in the period of last 50 days is set at 14.49%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 23.34%. In the last 20 days, the company’s Stochastic %K was 22.32% and its Stochastic %D was recorded 21.53%.

Let’s take a glance in the erstwhile performances of Inovio Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -62.32%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -73.89%, alongside a downfall of -73.37% for the period of the last 12 months. The shares increased approximately by -5.53% in the 7-day charts and went up by -34.49% in the period of the last 30 days. Common stock shares were lifted by -40.88% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts